127 related articles for article (PubMed ID: 17244784)
21. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: Is it hypoandrogenic?
de los Santos MJ; García-Laez V; Beltrán D; Labarta E; Zuzuarregui JL; Alamá P; Gámiz P; Crespo J; Bosch E; Pellicer A
Hum Reprod; 2013 Jan; 28(1):224-9. PubMed ID: 23019297
[TBL] [Abstract][Full Text] [Related]
22. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist.
Bo-Abbas YY; Martin KA; Liberman RF; Cramer DW; Barbieri RL
Fertil Steril; 2001 Apr; 75(4):694-9. PubMed ID: 11287021
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
[TBL] [Abstract][Full Text] [Related]
24. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
25. Concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-3 in the follicular fluid of women undergoing ovarian hyperstimulation with different gonadotropin preparations.
Nardo LG; Bellanca SA; Burrello N; Longo G; D'Agata R; Nardo F; Calogero AE
Gynecol Endocrinol; 2001 Dec; 15(6):413-20. PubMed ID: 11826764
[TBL] [Abstract][Full Text] [Related]
26. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization.
Keye WR; Marrs RP; Check JH; Schnell V; Surrey M; Marshall DC;
Fertil Steril; 2004 Aug; 82(2):348-57. PubMed ID: 15302283
[TBL] [Abstract][Full Text] [Related]
29. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
30. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
[TBL] [Abstract][Full Text] [Related]
31. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
32. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
[TBL] [Abstract][Full Text] [Related]
33. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
34. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotropin or human recombinant follicle-stimulating hormone (FSH)-induced ovulation and subsequent fertilization and early embryo development in hypophysectomized FSH-primed mice.
Wang XN; Greenwald GS
Endocrinology; 1993 May; 132(5):2009-16. PubMed ID: 8477652
[TBL] [Abstract][Full Text] [Related]
36. [Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].
Tsagareishvili GG
Georgian Med News; 2005 Feb; (119):18-23. PubMed ID: 15834173
[TBL] [Abstract][Full Text] [Related]
37. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
38. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.
Kolibianakis EM; Albano C; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
J Clin Endocrinol Metab; 2003 Dec; 88(12):5632-7. PubMed ID: 14671145
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
Karnitis VJ; Townson DH; Friedman CI; Danforth DR
J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
[TBL] [Abstract][Full Text] [Related]
40. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.
Schneyer AL; Fujiwara T; Fox J; Welt CK; Adams J; Messerlian GM; Taylor AE
J Clin Endocrinol Metab; 2000 Sep; 85(9):3319-30. PubMed ID: 10999828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
